{"ankylosing spondylitis": 16.19, "condition aggravated": 2.87, "drug hypersensitivity": 3.73, "drug ineffective": 5.85, "drug intolerance": 5.96, "gastric haemorrhage": 20.22, "gastrointestinal disorder": 3.12, "hepatic enzyme increased": 3.11, "inflammation": 5.83, "infusion related reaction": 5.25, "joint swelling": 5.15, "mobility decreased": 3.34, "mouth ulceration": 8.42, "musculoskeletal stiffness": 3.43, "product use in unapproved indication": 3.58, "psoriasis": 3.01, "psoriatic arthropathy": 9.19, "rheumatoid arthritis": 6.46, "therapeutic product effect incomplete": 3.66, "treatment failure": 7.19, "urinary tract infection": 2.9}